5-fluoro-N2-[2-(2-hydroxy-1,1-dimethylethylamino)carbonylbenzofuran-5-yl]-N4-(3-hydroxyphenyl)-2,4-pyrimidinediamine | 575480-21-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: 5-fluoro-N2-[2-(2-hydroxy-1,1-dimethylethylamino)carbonylbenzofuran-5-yl]-N4-(3-hydroxyphenyl)-2,4-pyrimidinediamine
• 英文别名: R926715；5-[[5-fluoro-4-(3-hydroxyanilino)pyrimidin-2-yl]amino]-N-(1-hydroxy-2-methylpropan-2-yl)-1-benzofuran-2-carboxamide
• CAS: 575480-21-6
• 化学式: C₂₃H₂₂FN₅O₄
• 分子量: 451.457
• InChiKey: PHGRTWGKNHSIBJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  133
• 氢给体数：
  5
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  、 5-fluoro-N4-(3-hydroxyphenyl)-N2-(2-methoxycarbonylbenzofuran-5-yl)-2,4-pyrimidinediamine 、 2-氨基-2-甲基-1-丙醇 以to yield 5-fluoro-N2-[2-(2-hydroxy-1,1-dimethylethylamino)carbonylbenzofuran-5-yl]-N4-(3-hydroxyphenyl)-2,4-pyrimidinediamine的产率得到5-fluoro-N2-[2-(2-hydroxy-1,1-dimethylethylamino)carbonylbenzofuran-5-yl]-N4-(3-hydroxyphenyl)-2,4-pyrimidinediamine
  参考文献：
  名称：

  Intermediates for making 2,4-pyrimidinediamine compounds

  摘要：

  本发明提供了2,4-嘧啶二胺化合物，其抑制IgE和/或IgG受体信号级联，从而导致化学介质释放，中间体和合成化合物的方法，并且利用这些化合物在各种情况下进行治疗和预防疾病，这些疾病的特征是通过脱颗粒化和其他由激活IgE和/或IgG受体信号级联引起的过程释放化学介质。某些公开的实施例涉及将具有以下公式或其盐或N-氧化物的化合物与2,4-二氯-5-氟嘧啶在条件下接触，以提供具有以下公式的化合物。

  公开号：

  US07655797B2

文献信息

• 2,4-Pyrimidinediamine Compounds and Their Uses
  申请人：Singh Rajinder

  公开号：US20150266828A1

  公开（公告）日：2015-09-24

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了抑制IgE和/或IgG受体信号级联反应的2,4-嘧啶二胺化合物，该级联反应导致化学介质的释放，以及合成这些化合物的中介体和方法，以及在多种情况下使用这些化合物的方法，包括在治疗和预防由脱粒和其他由IgE和/或IgG受体信号级联反应激活引起的化学介质释放所表征、引起或相关的疾病。
• 2, 4-pyrimidinediamine compounds and their uses
  申请人：Singh Rajinder

  公开号：US20050038243A1

  公开（公告）日：2005-02-17

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了抑制IgE和/或IgG受体信号级联，从而导致化学介质释放的2,4-嘧啶二胺化合物，以及合成这些化合物的中间体和方法，以及在多种情况下使用这些化合物的方法，包括在治疗和预防通过去颗粒化和其他由IgE和/或IgG受体信号级联激活的过程引起或与之相关的化学介质释放所表征的疾病中使用。
• 2,4-Pyrimidinediamine compounds and their uses
  申请人：——

  公开号：US20040029902A1

  公开（公告）日：2004-02-12

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了抑制IgE和/或IgG受体信号级联引起化学介质释放的2,4-嘧啶二胺化合物，以及合成这些化合物的中间体和方法，以及在多种情境下使用这些化合物的方法，包括在治疗和预防由通过激活IgE和/或IgG受体信号级联引起的脱颗粒化和其他过程释放化学介质的疾病中。
• 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
  申请人：Singh Rajinder

  公开号：US20070225321A1

  公开（公告）日：2007-09-27

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了能够抑制IgE和/或IgG受体信号级联反应从而导致化学介质释放的2,4-嘧啶二胺化合物，以及合成这些化合物的中间体和方法，以及在各种情况下使用这些化合物的方法，包括用于治疗和预防通过去颗粒化和其他通过激活IgE和/或IgG受体信号级联反应引起的化学介质释放所表征的，由化学介质引起或相关的疾病。
• 2,4-Pyrimidinediamine Compounds and their Uses
  申请人：SINGH Rajinder

  公开号：US20110144330A1

  公开（公告）日：2011-06-16

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了能够抑制IgE和/或IgG受体信号级联，从而导致化学介质释放的2,4-嘧啶二胺化合物，以及合成这些化合物的中间体和方法，以及在各种情况下使用这些化合物的方法，包括在通过去颗粒化和其他由IgE和/或IgG受体信号级联激活的过程引起的、由化学介质释放所表征、引起或相关的疾病的治疗和预防。